Similar articles

• Methylphenidate Treats Apathy in Alzheimer Disease.

  Slomski A. Slomski A. JAMA. 2021 Dec 7;326(21):2120. doi: 10.1001/jama.2021.20775. JAMA. 2021. PMID: 34874434 No abstract available.
• Improvement of glycemic control using methylphenidate treatment of apathy: a preliminary report.

  Padala PR, Padala KP, Sullivan DH, Reynolds DW, Desouza CV, Potter JF, Burke WJ. Padala PR, et al. J Am Geriatr Soc. 2012 Jul;60(7):1383-4. doi: 10.1111/j.1532-5415.2012.04010.x. J Am Geriatr Soc. 2012. PMID: 22788404 No abstract available.
• Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.

  Padala PR, Padala KP, Lensing SY, Ramirez D, Monga V, Bopp MM, Roberson PK, Dennis RA, Petty F, Sullivan DH, Burke WJ. Padala PR, et al. Am J Psychiatry. 2018 Feb 1;175(2):159-168. doi: 10.1176/appi.ajp.2017.17030316. Epub 2017 Sep 15. Am J Psychiatry. 2018. PMID: 28945120 Clinical Trial.
• Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.

  van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanctôt KL, Rosenberg PB. van Dyck CH, et al. Am J Geriatr Psychiatry. 2021 Jan;29(1):51-62. doi: 10.1016/j.jagp.2020.04.026. Epub 2020 May 5. Am J Geriatr Psychiatry. 2021. PMID: 32461027 Free PMC article. Review.
• Pharmacological Therapy for Apathy in Alzheimer's Disease: A Systematic Review and Meta-Analysis.

  Sepehry AA, Sarai M, Hsiung GR. Sepehry AA, et al. Can J Neurol Sci. 2017 May;44(3):267-275. doi: 10.1017/cjn.2016.426. Epub 2017 Feb 2. Can J Neurol Sci. 2017. PMID: 28148339 Review.